7 citations
,
April 2022 in “Cutis” This article discusses the rise of direct-to-consumer teledermatology platforms, warning that they might cause overdiagnosis, overtreatment, and fragmented healthcare, and emphasizes the need for patient counseling about these risks and benefits.
4 citations
,
March 2022 in “Journal of The American Academy of Dermatology” Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.
1 citations
,
January 2022 in “Journal of The American Academy of Dermatology” This article discusses various limitations of direct-to-consumer teledermatology platforms, highlighting concerns regarding ethical issues, financial conflicts of interest, and challenges in providing comprehensive patient care compared to traditional in-person consultations.
September 2025 in “JMIR Dermatology” This narrative review reported that direct-to-consumer teledermatology improves access to care, adherence, and patient satisfaction for treating male androgenetic alopecia, but may lead to higher drug costs.
January 2023 in “DIGITAL HEALTH” This study found that users of a German direct-to-consumer teledermatology platform for finasteride reported improvements in hair appearance and self-esteem, though 12% experienced treatment-related adverse events.
This review discusses the potential conflicts of interest and quality concerns associated with direct-to-consumer teledermatology platforms and reports no new experimental results.
5 citations
,
February 2021 in “Journal of The American Academy of Dermatology” This commentary discusses ethical concerns with direct-to-consumer teledermatology services, highlighting potential conflicts of interest and issues with care quality.
2 citations
,
November 2024 in “Australian Journal of General Practice” This abstract highlights the urgent need for rigorous research, quality assessment tools, and health economics analyses to integrate DTC telemedicine with traditional primary care for improved healthcare quality and efficiency.
April 2023 in “Clinical, Cosmetic and Investigational Dermatology” This study found that the increasing visits to online prescription platforms for MQ-based finasteride treatment in androgenetic alopecia suggest a significant shift in medical care towards digital health services.
March 2025 in “Journal of the American Academy of Dermatology” Discount pharmacies offer cheaper options for hair loss medications than traditional or direct-to-consumer pharmacies.
December 2024 in “Journal of the American Academy of Dermatology” Dermatologist visits offer safer and more ethical treatment for hair loss than direct-to-consumer platforms.
March 2023 in “Trends in Telemedicine & E-health” Medical questionnaires could modernize healthcare by improving access and efficiency but need guidelines to ensure quality care.
51 citations
,
April 2021 in “JAMA network open” This study found that artificial intelligence assistance improved diagnostic accuracy in dermatologic cases for primary care physicians and nurse practitioners, with higher agreement rates with reference diagnoses observed.
May 2024 in “Journal of cosmetic dermatology” This study found that topical finasteride mixed with minoxidil improved hair appearance and self-esteem in men with androgenetic alopecia, but it was not superior to oral finasteride and had lower treatment adherence.
January 2021 in “arXiv (Cornell University)” This study found that self-supervised pretraining significantly improves accuracy in medical image classifiers for dermatology and chest X-ray tasks, outperforming supervised baselines and showing robustness to distribution shifts with limited labeled data.
March 2014 in “Journal of The American Academy of Dermatology” The document lists various dermatology topics, treatments, and diagnostic methods.
101 citations
,
July 2020 in “Dermatologic therapy” This systematic review reports that "COVID toes" and other skin manifestations can be initial signs of COVID-19, and advises immunosuppressive therapy adjustments only for infected or at-risk patients.
84 citations
,
December 2018 in “Genetics in Medicine” This article reviews evidence- and consensus-based recommendations for using pegvaliase in adults with PKU and reports no new clinical results.
19 citations
,
October 2019 in “Dermatology Practical & Conceptual” This review discusses the expanding applications of dermoscopy in dermatological diagnosis beyond its initial use for detecting dysplastic nevi and reports no new clinical results.
In this study, long-term low-dose finasteride use in men with alopecia was associated with a significant reduction in the diagnosis of benign prostatic hyperplasia and prostate cancer, although further research is needed to understand the mechanisms and long-term effects.
This study evaluated AI chatbots' responses to scabies-related questions, finding DeepSeek had the highest accuracy despite higher hallucination rates, while ChatGPT-5.2 provided more readable and reliable information, highlighting variability and the need for cautious use of AI in health queries.
June 2026 in “International Journal of Research in Dermatology” This study found that Indulekha Bringha scalp serum significantly reduced hair shedding and improved hair density more effectively than 3% Redensyl serum in healthy Indian adults experiencing hair loss.
March 2026 in “Applied Sciences” In this scoping review, researchers observed that while AI-assisted trichoscopy holds promise for standardized assessments of hair and scalp disorders, its clinical translation is limited by small proprietary datasets, inconsistent validation protocols, and a scarcity of real-world clinical studies.
16 citations
,
October 2023 in “Molecular cancer” This study reviews the etiology and treatment of skin cancer, focusing on nanotechnology's role in addressing drug resistance and evaluating nanoparticles' potential to improve treatment outcomes, including overcoming multidrug resistance.
14 citations
,
September 2023 in “The Medical Journal of Australia” The researchers reported a rapid expansion of direct-to-consumer telemedicine services in Australia since the COVID-19 pandemic, driven by substantial investment and changes in telehealth regulations.
2 citations
,
September 2001 in “PubMed” Finasteride is advertised directly to consumers for treating male pattern hair loss.
February 2026 in “BMJ Open” In this assessment of existing research on DTC commercial virtual care, it is highlighted that impacts on care quality, health outcomes, system use, and privacy ethics remain unclear, with potential bias noted due to industry financial connections.
January 2026 in “Internal Medicine Journal” This study emphasizes the need for a formal evaluation of direct-to-consumer telemedicine services in Australia to ensure safety, privacy, and ethical standards while maintaining high-quality healthcare.
September 2024 in “Journal of the American Academy of Dermatology”
244 citations
,
September 2008 in “Annual Review of Genomics and Human Genetics” This review examines the direct-to-consumer genetic testing market, highlighting the available tests, regulatory issues, and calls for increased oversight, and reports no new results.